March Tip Sheet From Sylvester Comprehensive Cancer Center

A new study reported in JAMA Network Open unveils disparities in Mesothelioma survival, a grant to help construction workers nail quitting smoking, a new AI algorithm that offers insights into deadly cancer, a newly launched Neuroendocrine Tumors Program, a cancer researcher chosen to co-lead Tumor Biology Program and more are in this month’s tip sheet from Sylvester Comprehensive Cancer Center.

Antibiotic resistance is an increasing problem. Learn all about it in the Drug Resistance channel

Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.

Research Highlights for February 2023

Read how researchers discovered genetic markers that hinder pancreatic cancer treatment and mutations that increase sarcoma risk. Then learn how artificial intelligence is helping predict prostate cancer outcomes and see how a new clinical trial looks at less-invasive breast cancer treatments. Finally, find out how a new grant could help veterans get the cancer care they need.

MD Anderson Research Highlights for March 8, 2023

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

THT 2023 Late-Breaking Clinical Science Announced

The full list of late-breaking clinical science to be presented at THT 2023: Technology and Heart Failure Therapeutics is now available online. An international heart failure conference organized by the Cardiovascular Research Foundation (CRF), THT will take place March 20-22, 2023, at the Westin Boston Seaport in Boston, MA.

MD Anderson Research Highlights for February 22, 2023

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments include a new understanding of how HPV drives cancer development, a combination therapy to overcome treatment resistance in mantle cell lymphoma, novel insights into memory T cell formation and potential therapeutic strategies for brain cancers, improved survival outcomes for metastatic colorectal cancer, targeting myeloperoxidase to improve immunotherapy responses in melanoma, and preclinical results of a combination therapy that could effectively treat a subset of acute myeloid leukemia.

Hackensack Meridian JFK Johnson Rehabilitation Institute Physicians, Researchers To Present At The Association of Academic Physiatrists National Conference

“We welcome the opportunity to present the important research we’re doing at JFK Johnson to a national audience,” said Sara Cuccurullo, chair, vice president and medical director of JFK Johnson Rehabilitation Institute. “Our goal is to improve outcomes for our patients and also to advance the specialty of rehabilitation medicine to help patients everywhere.”

February Issue of AJG Features New Guideline on Acute Lower GI Bleeding

The February issue of The American Journal of Gastroenterology features a new ACG Clinical Guideline on Acute Lower GI Bleeding, a common reason for hospitalization in digestive diseases, which can be challenging to assess and triage.

Huntsman Cancer Institute Research Highlights for January 2023

Each month, we’d like to highlight some current work at Huntsman Cancer Institute. See how a potential new immunotherapy for breast cancer is being developed, learn about research being done to prevent cancer risks in young adults, gain an understanding of how a specific DNA mutation can change lung cancer tumors, check out how nurses are creating a new way to monitor a serious type of pneumonia, and read how researchers have linked biomarkers to distress in colorectal cancer patients.

MD Anderson Research Highlights for February 1, 2023

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

January Research Highlights

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Top Psychological Science Research Includes Flavor-Sensitive Fetuses and Less-Lonely Older Adults 

From a cranky-faced fetus scowling at her mother’s healthy lunch choice to an octogenarian still benefiting from long-ago musical lessons, the most impactful psychological science research published in 2022 reveals that new understandings of human behavior—studied across the lifespan and from within a remarkable diversity of topics and scientific subdisciplines—continue to resonate with wide audiences.

MD Anderson Research Highlights for December 19, 2022

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a cell cycle checkpoint inhibitor with potential therapeutic effects in an ovarian cancer subtype, a telementoring program for French-speaking oncology providers in Africa, insights into the relationship between obesity and immunotherapy side effects, updates to the world’s largest cancer drug discovery knowledgebase, improvements to treatment response by blocking the EGFR pathway, and a novel noninvasive diagnostic test for immunotherapy-related kidney injury.

MD Anderson Research Highlights: SABCS 2022 Special Edition

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into basic, translational and clinical cancer research from MD Anderson experts. This special edition features breast cancer presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS) focused on the combination of everolimus and hormone therapy, a new driver for brain metastases in inflammatory breast cancer, improving treatment for men with breast cancer, and a new understanding of the importance of HER2 expression for patients with early-stage triple-negative breast cancers.

MD Anderson Research Highlights: SITC 2022 Special Edition

This special edition features upcoming presentations by MD Anderson researchers at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, including immunotherapy advances in human papillomavirus (HPV)-positive head and neck cancers, microbiome signatures linked with specialized immune-cell clusters, and promising early activity from novel immunotherapy drugs in advanced melanoma and colorectal cancer.

New Psychological Science Findings Link Local Prejudice to Police Militarization, Offer Hope for Fostering Belief in Science

Findings also help explain why happy people are more optimistic, how false visual memories can be perpetuated, and why feeling good often just means feeling better.

MD Anderson Research Highlights: ESMO 2022 Special Edition

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. This special edition features upcoming oral presentations by MD Anderson researchers at the European Society for Medical Oncology (ESMO) Congress 2022 focused on clinical advances across a variety of cancer types. Highlights include promising early data from a novel T cell therapy for solid tumors, targeted therapy progress in rare and advanced cancers, biomarkers of immunotherapy response, and features associated with clinical outcomes in leptomeningeal disease. More information on ESMO content from MD Anderson can be found at MDAnderson.org/ESMO.